Development of Cytomegalovirus (CMV) Immune Recovery Uveitis Is Associated with Th17 Cell Depletion and Poor Systemic CMV-Specific T Cell Responses
Background. The immune reconstitution inflammatory syndromes (IRIS) are a spectrum of inflammatory conditions associated with opportunistic infections and occurring in ∼16% of human immunodeficiency type 1 (HIV-1)-infected patients given antiretroviral therapy. It has been proposed that these condit...
Saved in:
Published in | Clinical infectious diseases Vol. 52; no. 3; pp. 409 - 417 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Oxford
Oxford University Press
01.02.2011
|
Subjects | |
Online Access | Get full text |
ISSN | 1058-4838 1537-6591 1537-6591 |
DOI | 10.1093/cid/ciq112 |
Cover
Loading…
Abstract | Background. The immune reconstitution inflammatory syndromes (IRIS) are a spectrum of inflammatory conditions associated with opportunistic infections and occurring in ∼16% of human immunodeficiency type 1 (HIV-1)-infected patients given antiretroviral therapy. It has been proposed that these conditions are linked by a dysregulated immune system that is prone to exaggerated responses. However, immunologic studies have been limited by the availability of longitudinal samples from patients with IRIS and appropriate matched control subjects. Cytomegalovirus (CMV) immune recovery uveitis (IRU) is an IRIS occurring in up to 38% of patients with CMV retinitis. Although the pathologic immune responses occur in the eye, immune dysregulation that allows for development of pathologic responses is presumably caused by faulty systemic immune cell reconstitution. Methods. We examined CMV-specific T cell responses, regulatory T (T reg ) cell function and polyclonal T cell responses, including IL-17 production, in 25 patients with CMV IRU and 49 immunorestored control subjects with CMV retinitis who did not develop IRU. Results. Patients with CMV IRU had poor CMV-specific CD4 + T cell responses, as compared with control subjects, whereas CD8 + T cell responses were comparable. Patients with CMV IRU were characterized by smaller numbers of circulating Th17 cells. Deficiency in anti-CMV responses was not associated with differences in T reg cell function. Conclusions. The T reg cell compartment is intact in patients with CMV IRU, and these patients do not develop exaggerated systemic CMV-specific or polyclonal immune responses. Cases are instead characterized by more profound depletion of Th17 cells and poor antiviral immune responses. CMV IRU may be most likely to develop in persons experiencing the greatest degree of immune dysfunction before initiating highly active antiretroviral therapy. |
---|---|
AbstractList | The immune reconstitution inflammatory syndromes (IRIS) are a spectrum of inflammatory conditions associated with opportunistic infections and occurring in ~16% of human immunodeficiency type 1 (HIV-1)-infected patients given antiretroviral therapy. It has been proposed that these conditions are linked by a dysregulated immune system that is prone to exaggerated responses. However, immunologic studies have been limited by the availability of longitudinal samples from patients with IRIS and appropriate matched control subjects. Cytomegalovirus (CMV) immune recovery uveitis (IRU) is an IRIS occurring in up to 38% of patients with CMV retinitis. Although the pathologic immune responses occur in the eye, immune dysregulation that allows for development of pathologic responses is presumably caused by faulty systemic immune cell reconstitution. We examined CMV-specific T cell responses, regulatory T (T...) cell function and polyclonal T cell responses, including IL-17 production, in 25 patients with CMV IRU and 49 immunorestored control subjects with CMV retinitis who did not develop IRU. Patients with CMV IRU had poor CMV-specific CD4... T cell responses, as compared with control subjects, whereas CD8+ T cell responses were comparable. Patients with CMV IRU were characterized by smaller numbers of circulating Th17 cells. Deficiency in anti-CMV responses was not associated with differences in T... cell function. The T... cell compartment is intact in patients with CMV IRU, and these patients do not develop exaggerated systemic CMV-specific or polyclonal immune responses. Cases are instead characterized by more profound depletion of Th17 cells and poor antiviral immune responses. CMV IRU may be most likely to develop in persons experiencing the greatest degree of immune dysfunction before initiating highly active antiretroviral therapy. (ProQuest: ... denotes formulae/symbols omitted.) We tested whether impaired systemic immunoregulation and hyperactive immune responses are associated with an immune reconstitution inflammatory syndrome, CMV IRU. We found instead that T-regs in CMV IRU patients are functionally intact, while virus-specific immune responses and Th17 cells are compromised Background . The immune reconstitution inflammatory syndromes (IRIS) are a spectrum of inflammatory conditions associated with opportunistic infections and occurring in ∼16% of human immunodeficiency type 1 (HIV-1)–infected patients given antiretroviral therapy. It has been proposed that these conditions are linked by a dysregulated immune system that is prone to exaggerated responses. However, immunologic studies have been limited by the availability of longitudinal samples from patients with IRIS and appropriate matched control subjects. Cytomegalovirus (CMV) immune recovery uveitis (IRU) is an IRIS occurring in up to 38% of patients with CMV retinitis. Although the pathologic immune responses occur in the eye, immune dysregulation that allows for development of pathologic responses is presumably caused by faulty systemic immune cell reconstitution. Methods . We examined CMV-specific T cell responses, regulatory T (T reg ) cell function and polyclonal T cell responses, including IL-17 production, in 25 patients with CMV IRU and 49 immunorestored control subjects with CMV retinitis who did not develop IRU. Results . Patients with CMV IRU had poor CMV-specific CD4 + T cell responses, as compared with control subjects, whereas CD8 + T cell responses were comparable. Patients with CMV IRU were characterized by smaller numbers of circulating Th17 cells. Deficiency in anti-CMV responses was not associated with differences in T reg cell function. Conclusions . The T reg cell compartment is intact in patients with CMV IRU, and these patients do not develop exaggerated systemic CMV-specific or polyclonal immune responses. Cases are instead characterized by more profound depletion of Th17 cells and poor antiviral immune responses. CMV IRU may be most likely to develop in persons experiencing the greatest degree of immune dysfunction before initiating highly active antiretroviral therapy. Background. The immune reconstitution inflammatory syndromes (IRIS) are a spectrum of inflammatory conditions associated with opportunistic infections and occurring in ∼16% of human immunodeficiency type 1 (HIV-1)-infected patients given antiretroviral therapy. It has been proposed that these conditions are linked by a dysregulated immune system that is prone to exaggerated responses. However, immunologic studies have been limited by the availability of longitudinal samples from patients with IRIS and appropriate matched control subjects. Cytomegalovirus (CMV) immune recovery uveitis (IRU) is an IRIS occurring in up to 38% of patients with CMV retinitis. Although the pathologic immune responses occur in the eye, immune dysregulation that allows for development of pathologic responses is presumably caused by faulty systemic immune cell reconstitution. Methods. We examined CMV-specific T cell responses, regulatory T (T reg ) cell function and polyclonal T cell responses, including IL-17 production, in 25 patients with CMV IRU and 49 immunorestored control subjects with CMV retinitis who did not develop IRU. Results. Patients with CMV IRU had poor CMV-specific CD4 + T cell responses, as compared with control subjects, whereas CD8 + T cell responses were comparable. Patients with CMV IRU were characterized by smaller numbers of circulating Th17 cells. Deficiency in anti-CMV responses was not associated with differences in T reg cell function. Conclusions. The T reg cell compartment is intact in patients with CMV IRU, and these patients do not develop exaggerated systemic CMV-specific or polyclonal immune responses. Cases are instead characterized by more profound depletion of Th17 cells and poor antiviral immune responses. CMV IRU may be most likely to develop in persons experiencing the greatest degree of immune dysfunction before initiating highly active antiretroviral therapy. We tested whether impaired systemic immunoregulation and hyperactive immune responses are associated with an immune reconstitution inflammatory syndrome, CMV IRU. We found instead that T-regs in CMV IRU patients are functionally intact, while virus-specific immune responses and Th17 cells are compromised Background . The immune reconstitution inflammatory syndromes (IRIS) are a spectrum of inflammatory conditions associated with opportunistic infections and occurring in ∼16% of human immunodeficiency type 1 (HIV-1)–infected patients given antiretroviral therapy. It has been proposed that these conditions are linked by a dysregulated immune system that is prone to exaggerated responses. However, immunologic studies have been limited by the availability of longitudinal samples from patients with IRIS and appropriate matched control subjects. Cytomegalovirus (CMV) immune recovery uveitis (IRU) is an IRIS occurring in up to 38% of patients with CMV retinitis. Although the pathologic immune responses occur in the eye, immune dysregulation that allows for development of pathologic responses is presumably caused by faulty systemic immune cell reconstitution. Methods . We examined CMV-specific T cell responses, regulatory T (Treg) cell function and polyclonal T cell responses, including IL-17 production, in 25 patients with CMV IRU and 49 immunorestored control subjects with CMV retinitis who did not develop IRU. Results . Patients with CMV IRU had poor CMV-specific CD4+ T cell responses, as compared with control subjects, whereas CD8+ T cell responses were comparable. Patients with CMV IRU were characterized by smaller numbers of circulating Th17 cells. Deficiency in anti-CMV responses was not associated with differences in Treg cell function. Conclusions . The Treg cell compartment is intact in patients with CMV IRU, and these patients do not develop exaggerated systemic CMV-specific or polyclonal immune responses. Cases are instead characterized by more profound depletion of Th17 cells and poor antiviral immune responses. CMV IRU may be most likely to develop in persons experiencing the greatest degree of immune dysfunction before initiating highly active antiretroviral therapy. the immune reconstitution inflammatory syndromes (IRIS) are a spectrum of inflammatory conditions associated with opportunistic infections and occurring in approximately16% of human immunodeficiency type 1 (HIV-1)-infected patients given antiretroviral therapy. It has been proposed that these conditions are linked by a dysregulated immune system that is prone to exaggerated responses. However, immunologic studies have been limited by the availability of longitudinal samples from patients with IRIS and appropriate matched control subjects. Cytomegalovirus (CMV) immune recovery uveitis (IRU) is an IRIS occurring in up to 38% of patients with CMV retinitis. Although the pathologic immune responses occur in the eye, immune dysregulation that allows for development of pathologic responses is presumably caused by faulty systemic immune cell reconstitution.BACKGROUNDthe immune reconstitution inflammatory syndromes (IRIS) are a spectrum of inflammatory conditions associated with opportunistic infections and occurring in approximately16% of human immunodeficiency type 1 (HIV-1)-infected patients given antiretroviral therapy. It has been proposed that these conditions are linked by a dysregulated immune system that is prone to exaggerated responses. However, immunologic studies have been limited by the availability of longitudinal samples from patients with IRIS and appropriate matched control subjects. Cytomegalovirus (CMV) immune recovery uveitis (IRU) is an IRIS occurring in up to 38% of patients with CMV retinitis. Although the pathologic immune responses occur in the eye, immune dysregulation that allows for development of pathologic responses is presumably caused by faulty systemic immune cell reconstitution.we examined CMV-specific T cell responses, regulatory T (T(reg)) cell function and polyclonal T cell responses, including IL-17 production, in 25 patients with CMV IRU and 49 immunorestored control subjects with CMV retinitis who did not develop IRU.METHODSwe examined CMV-specific T cell responses, regulatory T (T(reg)) cell function and polyclonal T cell responses, including IL-17 production, in 25 patients with CMV IRU and 49 immunorestored control subjects with CMV retinitis who did not develop IRU.patients with CMV IRU had poor CMV-specific CD4(+) T cell responses, as compared with control subjects, whereas CD8(+) T cell responses were comparable. Patients with CMV IRU were characterized by smaller numbers of circulating Th17 cells. Deficiency in anti-CMV responses was not associated with differences in T(reg) cell function.RESULTSpatients with CMV IRU had poor CMV-specific CD4(+) T cell responses, as compared with control subjects, whereas CD8(+) T cell responses were comparable. Patients with CMV IRU were characterized by smaller numbers of circulating Th17 cells. Deficiency in anti-CMV responses was not associated with differences in T(reg) cell function.the T(reg) cell compartment is intact in patients with CMV IRU, and these patients do not develop exaggerated systemic CMV-specific or polyclonal immune responses. Cases are instead characterized by more profound depletion of Th17 cells and poor antiviral immune responses. CMV IRU may be most likely to develop in persons experiencing the greatest degree of immune dysfunction before initiating highly active antiretroviral therapy.CONCLUSIONSthe T(reg) cell compartment is intact in patients with CMV IRU, and these patients do not develop exaggerated systemic CMV-specific or polyclonal immune responses. Cases are instead characterized by more profound depletion of Th17 cells and poor antiviral immune responses. CMV IRU may be most likely to develop in persons experiencing the greatest degree of immune dysfunction before initiating highly active antiretroviral therapy. the immune reconstitution inflammatory syndromes (IRIS) are a spectrum of inflammatory conditions associated with opportunistic infections and occurring in approximately16% of human immunodeficiency type 1 (HIV-1)-infected patients given antiretroviral therapy. It has been proposed that these conditions are linked by a dysregulated immune system that is prone to exaggerated responses. However, immunologic studies have been limited by the availability of longitudinal samples from patients with IRIS and appropriate matched control subjects. Cytomegalovirus (CMV) immune recovery uveitis (IRU) is an IRIS occurring in up to 38% of patients with CMV retinitis. Although the pathologic immune responses occur in the eye, immune dysregulation that allows for development of pathologic responses is presumably caused by faulty systemic immune cell reconstitution. we examined CMV-specific T cell responses, regulatory T (T(reg)) cell function and polyclonal T cell responses, including IL-17 production, in 25 patients with CMV IRU and 49 immunorestored control subjects with CMV retinitis who did not develop IRU. patients with CMV IRU had poor CMV-specific CD4(+) T cell responses, as compared with control subjects, whereas CD8(+) T cell responses were comparable. Patients with CMV IRU were characterized by smaller numbers of circulating Th17 cells. Deficiency in anti-CMV responses was not associated with differences in T(reg) cell function. the T(reg) cell compartment is intact in patients with CMV IRU, and these patients do not develop exaggerated systemic CMV-specific or polyclonal immune responses. Cases are instead characterized by more profound depletion of Th17 cells and poor antiviral immune responses. CMV IRU may be most likely to develop in persons experiencing the greatest degree of immune dysfunction before initiating highly active antiretroviral therapy. |
Author | Hartigan-O'Connor, Dennis J. Tan, Qi Xuan Jacobson, Mark A. Sinclair, Elizabeth |
AuthorAffiliation | 2 Positive Health Program, Department of Medicine, University of California, San Francisco 1 Division of Experimental Medicine a Study group members are listed in supplementary appendix |
AuthorAffiliation_xml | – name: 2 Positive Health Program, Department of Medicine, University of California, San Francisco – name: a Study group members are listed in supplementary appendix – name: 1 Division of Experimental Medicine |
Author_xml | – sequence: 1 givenname: Dennis J. surname: Hartigan-O'Connor fullname: Hartigan-O'Connor, Dennis J. – sequence: 2 givenname: Mark A. surname: Jacobson fullname: Jacobson, Mark A. – sequence: 3 givenname: Qi Xuan surname: Tan fullname: Tan, Qi Xuan – sequence: 4 givenname: Elizabeth surname: Sinclair fullname: Sinclair, Elizabeth |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23838739$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/21189271$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkl1vFCEUhiemxn7ojfcaYmKqJqMwzCzMjUmz9WOTGk279ZYwzKHLZgamwKzZ39E_LJtdW22MXhAgPLy8nPMeZnvWWciypwS_Jbim75Rp07gmpHiQHZCKsnxS1WQvrXHF85JTvp8dhrDEmBCOq0fZfpEWdcHIQXZzCivo3NCDjchpNF1H18OV7NzK-DGgV9Mv31-jWd-PFtA5KLcCv0aXKzDRBDQL6CQEp4yM0KIfJi7QfEEYmkLXoVMYOojGWSRti74559HFOkTojUJJNb8YQBmdNvMtfw5hcDZAeJw91LIL8GQ3H2WXHz_Mp5_zs6-fZtOTs1xVhMe8bGpFNatpwXlTc0mVJqWuqcZcYyBFUWDGS4obpWvgSjVFK3ULBFghy2LS0KPs_VZ3GJseWpVK4GUnBm966dfCSSP-PLFmIa7cSlA8wZxPksDxTsC76xFCFL0JKv1FWnBjEJxzgie0Lv9PlqzgFalYIl_cI5du9DbVQfAqPUxKXifo-e_Oby3_6msCXu4AGZTstJdWmXDH0RQKRjdCb7ac8i4ED_oWIVhswiVSuMQ2XAnG92Blotx0OFXHdH-_svPhxuHf0s-23DJE5-98spowVpb0J1OD6cw |
CODEN | CIDIEL |
CitedBy_id | crossref_primary_10_1093_cid_cir276 crossref_primary_10_1093_ofid_ofz113 crossref_primary_10_1182_blood_2011_09_380840 crossref_primary_10_1016_j_revmed_2018_02_017 crossref_primary_10_4103_ijo_IJO_1583_20 crossref_primary_10_1097_ICU_0000000000001078 crossref_primary_10_1097_QCO_0b013e32834ab20a crossref_primary_10_1097_QCO_0b013e328352b664 crossref_primary_10_1093_cid_ciu201 crossref_primary_10_3109_09273948_2013_779725 crossref_primary_10_1016_j_jiac_2017_03_002 crossref_primary_10_1097_TP_0b013e31828719c8 crossref_primary_10_1155_2014_971417 crossref_primary_10_1186_s12348_016_0110_3 crossref_primary_10_1007_s00430_015_0415_0 crossref_primary_10_1097_MD_0000000000006878 crossref_primary_10_1007_s00417_024_06415_y crossref_primary_10_1016_j_jve_2021_100052 |
Cites_doi | 10.1016/j.jim.2006.10.008 10.1128/CMR.00015-09 10.1097/01.aids.0000166100.36638.97 10.1002/eji.200838630 10.1086/525853 10.1182/blood-2010-05-286336 10.1097/QAD.0b013e328011efac 10.1016/S1473-3099(10)70026-8 10.1182/blood-2008-05-159301 10.1038/83713 10.1371/journal.ppat.1000295 10.1097/01.aids.0000202648.18526.bf 10.1086/342044 10.4049/jimmunol.155.3.1151 10.1016/S0002-9394(99)80149-4 10.1016/S0022-1759(03)00265-5 |
ContentType | Journal Article |
Copyright | Copyright © 2011 Oxford University Press on behalf of the Infectious Diseases Society of America The Author 2011. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. 2011 2015 INIST-CNRS Copyright University of Chicago, acting through its Press Feb 1, 2011 |
Copyright_xml | – notice: Copyright © 2011 Oxford University Press on behalf of the Infectious Diseases Society of America – notice: The Author 2011. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. 2011 – notice: 2015 INIST-CNRS – notice: Copyright University of Chicago, acting through its Press Feb 1, 2011 |
CorporateAuthor | Studies of Ocular Complications of AIDS Research Group |
CorporateAuthor_xml | – name: Studies of Ocular Complications of AIDS Research Group |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7QL 7T2 7T7 7U7 7U9 8FD C1K FR3 H94 K9. M7N P64 7X8 5PM |
DOI | 10.1093/cid/ciq112 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Bacteriology Abstracts (Microbiology B) Health and Safety Science Abstracts (Full archive) Industrial and Applied Microbiology Abstracts (Microbiology A) Toxicology Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Virology and AIDS Abstracts Technology Research Database Toxicology Abstracts Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Safety Science Abstracts Engineering Research Database Industrial and Applied Microbiology Abstracts (Microbiology A) Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | Virology and AIDS Abstracts Health & Safety Science Abstracts MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1537-6591 |
EndPage | 417 |
ExternalDocumentID | PMC3060886 2273043771 21189271 23838739 10_1093_cid_ciq112 10.1093/cid/ciq112 27917744 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural Feature |
GrantInformation_xml | – fundername: NIAID NIH HHS grantid: P30AI027763 – fundername: NIAID NIH HHS grantid: K23 AI081540 – fundername: NCRR NIH HHS grantid: UL1 RR024131 – fundername: NIAID NIH HHS grantid: P30 AI027763 – fundername: NEI NIH HHS grantid: R21 EY018559 |
GroupedDBID | --- ..I .2P .I3 .ZR 08P 0R~ 1TH 29B 2AX 2WC 36B 4.4 48X 53G 5GY 5RE 5VS 5WD 6J9 70D AABZA AACGO AACZT AAJKP AAJQQ AAMVS AANCE AAOGV AAPQZ AAPXW AAQQT AARHZ AAUAY AAUQX AAVAP ABBHK ABDFA ABEJV ABEUO ABGNP ABIXL ABJNI ABLJU ABNHQ ABOCM ABPLY ABPQP ABPTD ABQLI ABQNK ABTLG ABVGC ABWST ABXSQ ABXVV ACGFO ACGFS ACHIC ACPRK ACUFI ACUTJ ACUTO ACYHN ADBBV ADGZP ADHKW ADHZD ADIPN ADNBA ADQBN ADQXQ ADRTK ADULT ADVEK ADYVW ADZXQ AEGPL AEGXH AEJOX AEKSI AEMDU AEMQT AENEX AENZO AEPUE AETBJ AEUPB AEWNT AEXZC AFFNX AFFZL AFIYH AFOFC AFRAH AFXAL AGINJ AGORE AGQXC AGSYK AGUTN AHMBA AHMMS AHXPO AIAGR AJBYB AJEEA AJNCP ALMA_UNASSIGNED_HOLDINGS ALUQC ALXQX APIBT APWMN AQKUS AQVQM ATGXG AXUDD BAWUL BAYMD BCRHZ BEYMZ BHONS BTRTY BVRKM C1A C45 CDBKE CS3 CZ4 DAKXR DCCCD DIK DILTD DU5 D~K E3Z EBS EE~ EJD EMOBN ENERS F5P F9B FECEO FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC H13 H5~ HAR HW0 HZ~ IOX IPSME J21 JAAYA JBMMH JENOY JHFFW JKQEH JLS JLXEF JPM JSG JST JXSIZ KAQDR KBUDW KOP KSI KSN L7B MHKGH MJL ML0 N9A NGC NOMLY NOYVH NU- NVLIB O0~ O9- OAUYM OAWHX OCZFY ODMLO ODZKP OJQWA OJZSN OK1 OPAEJ OVD OWPYF P2P P6G PAFKI PEELM PQQKQ Q1. Q5Y QBD RD5 ROX ROZ RUSNO RW1 RXO SA0 SJN TCURE TEORI TJX TMA TR2 W8F X7H YAYTL YKOAZ YXANX ~91 ~S- AASNB ADACV ADJQC ADRIX AFXEN DOOOF ESX JSODD M49 AAYXX CITATION .GJ 1KJ 3O- AAPGJ AAPNW AAWDT ABKDP ABNGD ABNKS ABSMQ ABZBJ ACFRR ACPQN ACUKT ACVCV ACZBC ADEYI ADMTO ADOCK AEKPW AFFQV AFSHK AFYAG AGKEF AGKRT AGMDO AGQPQ AHGBF AI. AIJHB AJDVS APJGH AQDSO ASPBG AVNTJ AVWKF AZFZN BZKNY EIHJH FEDTE HQ3 HTVGU HVGLF IQODW J5H MBLQV N4W OBFPC O~Y PB- VH1 Y6R ZGI CGR CUY CVF ECM EIF NPM 7QL 7T2 7T7 7U7 7U9 8FD C1K FR3 H94 K9. M7N P64 7X8 5PM |
ID | FETCH-LOGICAL-c518t-4b9c3f793288b98a3cf14f93f08f0e1222078430bcf9e8ccb2dafde1e72a426b3 |
ISSN | 1058-4838 1537-6591 |
IngestDate | Thu Aug 21 14:00:42 EDT 2025 Fri Jul 11 15:55:23 EDT 2025 Fri Jul 11 06:39:32 EDT 2025 Mon Jun 30 03:38:03 EDT 2025 Mon Jul 21 05:39:02 EDT 2025 Mon Jul 21 09:14:17 EDT 2025 Tue Jul 01 01:25:50 EDT 2025 Thu Apr 24 23:04:57 EDT 2025 Wed Sep 11 04:49:13 EDT 2024 Thu Jun 19 15:34:22 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Herpesviridae Immune reconstitution Uvea disease Betaherpesvirinae Human cytomegalovirus Infection Virus Eye disease Immunological investigation Viral disease T-Lymphocyte Uveitis Disseminated |
Language | English |
License | CC BY 4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c518t-4b9c3f793288b98a3cf14f93f08f0e1222078430bcf9e8ccb2dafde1e72a426b3 |
Notes | SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC3060886 |
PMID | 21189271 |
PQID | 853061489 |
PQPubID | 48300 |
PageCount | 9 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3060886 proquest_miscellaneous_888106394 proquest_miscellaneous_847285157 proquest_journals_853061489 pubmed_primary_21189271 pascalfrancis_primary_23838739 crossref_primary_10_1093_cid_ciq112 crossref_citationtrail_10_1093_cid_ciq112 oup_primary_10_1093_cid_ciq112 jstor_primary_27917744 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2011-02-01 |
PublicationDateYYYYMMDD | 2011-02-01 |
PublicationDate_xml | – month: 02 year: 2011 text: 2011-02-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Oxford |
PublicationPlace_xml | – name: Oxford – name: United States |
PublicationTitle | Clinical infectious diseases |
PublicationTitleAlternate | Clin Infect Dis |
PublicationYear | 2011 |
Publisher | Oxford University Press |
Publisher_xml | – name: Oxford University Press |
References | Mutimer ( key 20170425181130_bib11) 2002; 186 Kosobucki ( key 20170425181130_bib17) 2004; 137 Hartigan-O'Connor ( key 20170425181130_bib6) 2007; 319 Brenchley ( key 20170425181130_bib13) 2008; 112 Favre ( key 20170425181130_bib12) 2009; 5 Price ( key 20170425181130_bib1) 2009; 22 Ortega-Larrocea ( key 20170425181130_bib16) 2005; 19 Bennett ( key 20170425181130_bib7) 2001; 27 Muller ( key 20170425181130_bib2) 2010; 10 Jacobson ( key 20170425181130_bib8) 2008; 46 Betts ( key 20170425181130_bib9) 2003; 281 Seddiki ( key 20170425181130_bib5) 2009; 39 Bourgarit ( key 20170425181130_bib14) 2006; 20 Lawn ( key 20170425181130_bib3) 2007; 21 Nussenblatt ( key 20170425181130_bib4) 1998; 125 Barber ( key 20170425181130_bib15) 2010; 116 Sakaguchi ( key 20170425181130_bib10) 1995; 155 16511406 - AIDS. 2006 Jan 9;20(2):F1-7 18173357 - Clin Infect Dis. 2008 Feb 1;46(3):458-66 18664624 - Blood. 2008 Oct 1;112(7):2826-35 7636184 - J Immunol. 1995 Aug 1;155(3):1151-64 15059701 - Am J Ophthalmol. 2004 Apr;137(4):636-8 19822893 - Clin Microbiol Rev. 2009 Oct;22(4):651-63 12195359 - J Infect Dis. 2002 Sep 1;186(5):701-5 20656932 - Blood. 2010 Nov 4;116(18):3485-93 14580882 - J Immunol Methods. 2003 Oct 1;281(1-2):65-78 19180462 - Eur J Immunol. 2009 Feb;39(2):391-403 9512156 - Am J Ophthalmol. 1998 Mar;125(3):374-82 20334848 - Lancet Infect Dis. 2010 Apr;10(4):251-61 19214220 - PLoS Pathog. 2009 Feb;5(2):e1000295 17173927 - J Immunol Methods. 2007 Jan 30;319(1-2):41-52 15821403 - AIDS. 2005 Apr 29;19(7):735-8 11137993 - Nat Genet. 2001 Jan;27(1):20-1 17255740 - AIDS. 2007 Jan 30;21(3):335-41 |
References_xml | – volume: 319 start-page: 41 year: 2007 ident: key 20170425181130_bib6 article-title: Human CD4+ regulatory T cells express lower levels of the IL-7 receptor alpha chain (CD127), allowing consistent identification and sorting of live cells publication-title: J Immunol Methods doi: 10.1016/j.jim.2006.10.008 – volume: 22 start-page: 651 year: 2009 ident: key 20170425181130_bib1 article-title: Immune restoration diseases reflect diverse immunopathological mechanisms publication-title: Clin Microbiol Rev doi: 10.1128/CMR.00015-09 – volume: 19 start-page: 735 year: 2005 ident: key 20170425181130_bib16 article-title: Lower incidence and severity of cytomegalovirus-associated immune recovery uveitis in HIV-infected patients with delayed highly active antiretroviral therapy publication-title: AIDS doi: 10.1097/01.aids.0000166100.36638.97 – volume: 39 start-page: 391 year: 2009 ident: key 20170425181130_bib5 article-title: Proliferation of weakly suppressive regulatory CD4+ T cells is associated with over-active CD4+ T-cell responses in HIV-positive patients with mycobacterial immune restoration disease publication-title: Eur J Immunol doi: 10.1002/eji.200838630 – volume: 46 start-page: 458 year: 2008 ident: key 20170425181130_bib8 article-title: Poor predictive value of cytomegalovirus (CMV)-specific T cell assays for the development of CMV retinitis in patients with AIDS publication-title: Clin Infect Dis doi: 10.1086/525853 – volume: 116 start-page: 3485 year: 2010 ident: key 20170425181130_bib15 article-title: Th1 publication-title: Blood doi: 10.1182/blood-2010-05-286336 – volume: 21 start-page: 335 year: 2007 ident: key 20170425181130_bib3 article-title: Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa publication-title: AIDS doi: 10.1097/QAD.0b013e328011efac – volume: 10 start-page: 251 year: 2010 ident: key 20170425181130_bib2 article-title: Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(10)70026-8 – volume: 112 start-page: 2826 year: 2008 ident: key 20170425181130_bib13 article-title: Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections publication-title: Blood doi: 10.1182/blood-2008-05-159301 – volume: 27 start-page: 20 year: 2001 ident: key 20170425181130_bib7 article-title: The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 publication-title: Nat Genet doi: 10.1038/83713 – volume: 5 start-page: e1000295 year: 2009 ident: key 20170425181130_bib12 article-title: Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1000295 – volume: 20 start-page: F1 year: 2006 ident: key 20170425181130_bib14 article-title: Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients publication-title: AIDS doi: 10.1097/01.aids.0000202648.18526.bf – volume: 186 start-page: 701 year: 2002 ident: key 20170425181130_bib11 article-title: Association between immune recovery uveitis and a diverse intraocular cytomegalovirus-specific cytotoxic T cell response publication-title: J Infect Dis doi: 10.1086/342044 – volume: 137 start-page: 636 year: 2004 ident: key 20170425181130_bib17 article-title: Valganciclovir therapy for immune recovery uveitis complicated by macular edema publication-title: Am J Ophthalmol – volume: 155 start-page: 1151 year: 1995 ident: key 20170425181130_bib10 article-title: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases publication-title: J Immunol doi: 10.4049/jimmunol.155.3.1151 – volume: 125 start-page: 374 year: 1998 ident: key 20170425181130_bib4 article-title: Human immunodeficiency virus disease: changing patterns of intraocular inflammation publication-title: Am J Ophthalmol doi: 10.1016/S0002-9394(99)80149-4 – volume: 281 start-page: 65 year: 2003 ident: key 20170425181130_bib9 article-title: Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation publication-title: J Immunol Methods doi: 10.1016/S0022-1759(03)00265-5 – reference: 15059701 - Am J Ophthalmol. 2004 Apr;137(4):636-8 – reference: 19214220 - PLoS Pathog. 2009 Feb;5(2):e1000295 – reference: 18173357 - Clin Infect Dis. 2008 Feb 1;46(3):458-66 – reference: 19180462 - Eur J Immunol. 2009 Feb;39(2):391-403 – reference: 7636184 - J Immunol. 1995 Aug 1;155(3):1151-64 – reference: 18664624 - Blood. 2008 Oct 1;112(7):2826-35 – reference: 20656932 - Blood. 2010 Nov 4;116(18):3485-93 – reference: 12195359 - J Infect Dis. 2002 Sep 1;186(5):701-5 – reference: 11137993 - Nat Genet. 2001 Jan;27(1):20-1 – reference: 9512156 - Am J Ophthalmol. 1998 Mar;125(3):374-82 – reference: 19822893 - Clin Microbiol Rev. 2009 Oct;22(4):651-63 – reference: 20334848 - Lancet Infect Dis. 2010 Apr;10(4):251-61 – reference: 15821403 - AIDS. 2005 Apr 29;19(7):735-8 – reference: 17255740 - AIDS. 2007 Jan 30;21(3):335-41 – reference: 17173927 - J Immunol Methods. 2007 Jan 30;319(1-2):41-52 – reference: 16511406 - AIDS. 2006 Jan 9;20(2):F1-7 – reference: 14580882 - J Immunol Methods. 2003 Oct 1;281(1-2):65-78 |
SSID | ssj0011805 |
Score | 2.1215475 |
Snippet | Background. The immune reconstitution inflammatory syndromes (IRIS) are a spectrum of inflammatory conditions associated with opportunistic infections and... We tested whether impaired systemic immunoregulation and hyperactive immune responses are associated with an immune reconstitution inflammatory syndrome, CMV... the immune reconstitution inflammatory syndromes (IRIS) are a spectrum of inflammatory conditions associated with opportunistic infections and occurring in... The immune reconstitution inflammatory syndromes (IRIS) are a spectrum of inflammatory conditions associated with opportunistic infections and occurring in... |
SourceID | pubmedcentral proquest pubmed pascalfrancis crossref oup jstor |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 409 |
SubjectTerms | Adult Aged AIDS Anti-Retroviral Agents - adverse effects Anti-Retroviral Agents - therapeutic use Antiretroviral drugs Biological and medical sciences Cytokines Cytomegalovirus Cytomegalovirus - immunology Cytomegalovirus - pathogenicity Cytomegalovirus Infections - immunology Cytomegalovirus Infections - pathology Cytomegalovirus Infections - virology Female Highly active antiretroviral therapy HIV HIV Infections - complications HIV Infections - drug therapy HIV/AIDS Human immunodeficiency virus Humans Immune Reconstitution Inflammatory Syndrome Immune system Immunology Infectious diseases Iris Lymphocytes Male Medical sciences Middle Aged Nadir Ophthalmology T cell receptors T lymphocytes T-Lymphocyte Subsets - immunology Th17 Cells - immunology Tuberculosis Uvea diseases Uveitis Uveitis - immunology Uveitis - virology Viral diseases Vitamin deficiency |
Title | Development of Cytomegalovirus (CMV) Immune Recovery Uveitis Is Associated with Th17 Cell Depletion and Poor Systemic CMV-Specific T Cell Responses |
URI | https://www.jstor.org/stable/27917744 https://www.ncbi.nlm.nih.gov/pubmed/21189271 https://www.proquest.com/docview/853061489 https://www.proquest.com/docview/847285157 https://www.proquest.com/docview/888106394 https://pubmed.ncbi.nlm.nih.gov/PMC3060886 |
Volume | 52 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBASQtw2yqCyBA9MVVguTpM8onbTOrZxS1Hfoti1tUgjKU07afwN_gI_lHPi3FqmcXmJmvjUsXS-2Occfz6HkFfKjK2B8rihxEwZTCnXiC0lDeYHseKwfsEdsi3OBkcTdjx1p53OzxZrabXkb8T3a8-V_I9W4RnoFU_J_oNm607hAfwG_cIVNAzXv9Jxi_FT0CqultlXCVN-dpksVkU4dXj6Bf3-MZ4CwQoNAhmbV_3JpcRcRv1xXuunoqGH55bXH2JEbyTnmJm7pCt_yLJFmd88EX3o1yhK1yu4CbX8J023LUmJVfaD6uRlxfqCcZWbQnkz-y0w00dqVMwbHUIYIfEmb_atjmHyrqqd4xGjJgwb6ijux6Q_XTVo_5yk4iJOFpvstTrKgWHbmjGiJ2bTLQKffnvmdu0WQp3WNMzMoLWil3e_LRY6kZYowCGSb1bJ517LyX32PjqcnJxE4cE0vEVu2-CMYJ2M0fhdvVdl-QVRth5hlQQ3cPah733d85rZo5mv1ZHKe_M4Bz0oXUjlOk9nk7DbsoDCB-R-6brQtxqHD0lHpo_IndOSnPGY_GjBkWaKbsCRvgbQ7FENRVpBkZZQpOOcNlCkCEWKUKQILVpDkQIUKUKRVlCkbSjSUMvXUHxCJocH4fDIKGt-GMK1_KXBeCAcBYuG7fs88GNHKIupwFGmr0xpgTULNi1zTC5UIH0huD2L1Uxa0rNjMDa5s0220iyVTwn1uMMZ2O8u45wFruK2lJ7JFBNc4u56l-xVKolEmRAf67JcRJqY4URY1Vqrr0te1rJznQbmWqntQrO1iO0FFvhXrEt6oOob_9lbQ0HTgwOI8pygS3YrWETlDJRHYGpjQMeHVlq3wvKAe35xKuGLjsD4tMGpcr0bRHzfQkcFRrmjYda8HcAd2J7VJd4aAGsBTE6_3pIm50WSehgZGDCDZ39-7S6523zxz8nWcrGSL8DSX_Je8aH9Ak3oBtc |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Development+of+Cytomegalovirus+%28CMV%29+Immune+Recovery+Uveitis+Is+Associated+with+Th17+Cell+Depletion+and+Poor+Systemic+CMV-Specific+T+Cell+Responses&rft.jtitle=Clinical+infectious+diseases&rft.au=Hartigan-O%27Connor%2C+Dennis+J&rft.au=Jacobson%2C+Mark+A&rft.au=Tan%2C+Qi+Xuan&rft.au=Sinclair%2C+Elizabeth&rft.date=2011-02-01&rft.issn=1058-4838&rft.volume=52&rft.issue=3&rft.spage=409&rft.epage=409&rft_id=info:doi/10.1093%2Fcid%2Fciq112&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1058-4838&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1058-4838&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1058-4838&client=summon |